Nimish Patel

Title(s)Professor Of Clinical, School of Pharmacy and Pharmaceutical Science
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
ORCID ORCID Icon0000-0003-0921-549X Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Albany College of Pharmacy & Health Sciences, Albany, NYPharmD05/2006Pharmacy
    State University of New York, University at Albany, Albany, NYMS12/2009Epidemiology
    State University of New York, University at Albany, Albany, NYPhD05/2014Epidemiology

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Featured Content 
    Collapse Twitter

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Access to community pharmacies: A nationwide geographic information systems cross-sectional analysis. J Am Pharm Assoc (2003). 2022; 62(6):1816-1822.e2. Berenbrok LA, Tang S, Gabriel N, Guo J, Sharareh N, Patel N, Dickson S, Hernandez I. PMID: 35965233.
      View in: PubMed   Mentions:
    2. Prevalence and Predictors of Pseudomonas aeruginosa Among Hospitalized Patients With Diabetic Foot Infections. Open Forum Infect Dis. 2022 Jul; 9(7):ofac297. Veve MP, Mercuro NJ, Sangiovanni RJ, Santarossa M, Patel N. PMID: 35873292; PMCID: PMC9301575.
      View in: PubMed   Mentions:
    3. Method of Calculating Renal Function Estimates Could Inappropriately Exclude Transgender Patients Receiving Gender-Affirming Hormone Therapy from Pre-Exposure Prophylaxis Eligibility. LGBT Health. 2022 04; 9(3):199-206. Patel N, Blumenthal J, Dubé MP, Hood A, Bolan R, Morris S. PMID: 35196473.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    4. Characterisation of infections in patients with acute myeloid leukaemia receiving venetoclax and a hypomethylating agent. Br J Haematol. 2022 04; 197(1):63-70. On S, Rath CG, Lan M, Wu B, Lau KM, Cheung E, Alegria W, Young R, Tan M, Kim C, Phun J, Patel N, Mannis G, Logan AC, Kennedy V, Goodman A, Taplitz RA, Young PA, Wen R, Saunders IM. PMID: 35174480.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Brief Report: Pharmacokinetics of Bictegravir and Tenofovir in Combination With Darunavir/Cobicistat in Treatment-Experienced Persons With HIV. J Acquir Immune Defic Syndr. 2021 12 01; 88(4):389-392. Salama E, Hill L, Patel N, Best BM, Momper JD. PMID: 34285156.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Overcoming Past Perceptions and a Profession-Wide Identity Crisis to Reflect Pharmacy's Future. Am J Pharm Educ. 2022 Oct; 86(7):8829. Wagner JL, Boyle J, Boyle CJ, Choi D, Ballou JM, Patel N, Persky AM, Malcom DR. PMID: 34785501.
      View in: PubMed   Mentions:    Fields:    
    7. US-Focused Conceptual Health Care Decision-Analytic Models Examining the Value of Pivmecillinam Relative to Current Standard-of-Care Agents Among Adult Patients With Uncomplicated Urinary Tract Infections due to Enterobacterales. Open Forum Infect Dis. 2021 Oct; 8(10):ofab380. Lodise TP, Henriksen AS, Hadley T, Patel N. PMID: 34660834; PMCID: PMC8516593.
      View in: PubMed   Mentions: 1  
    8. Early clinical trial data and real-world assessment of COVID-19 vaccines: Insights from the Society of Infectious Diseases Pharmacists. Pharmacotherapy. 2021 Oct; 41(10):837-850. Patel N, Bouchard J, Oliver MB, Badowski ME, Carreno JJ, Society of Infectious Diseases Pharmacists. PMID: 34689348; PMCID: PMC8662264.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    9. Potential Cost Savings Associated with Targeted Substitution of Current Guideline-Concordant Inpatient Agents with Omadacycline for the Treatment of Adult Hospitalized Patients with Community-Acquired Bacterial Pneumonia at High Risk for Clostridioides difficile Infections: Results of Healthcare-Decision Analytic Model from the United States Hospital Perspective. Antibiotics (Basel). 2021 Oct 01; 10(10). Lodise T, Rodriguez M, Chitra S, Wright K, Patel N. PMID: 34680776; PMCID: PMC8532985.
      View in: PubMed   Mentions:
    10. Comparative effectiveness of early-targeted use of fidaxomicin versus oral vancomycin among hospitalized veterans' affairs patients with infections due to Clostridioides difficile. Pharmacotherapy. 2021 Feb; 41(2):212-219. Patel N, Lowry C, Morgenson D, Shah V, Stornelli N, Lodise TP. PMID: 33455007.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    11. Comparison of dalbavancin to standard-of-care for outpatient treatment of invasive Gram-positive infections. Int J Antimicrob Agents. 2020 Dec; 56(6):106210. Veve MP, Patel N, Smith ZA, Yeager SD, Wright LR, Shorman MA. PMID: 33223119.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    12. Effect of Vancomycin-Associated Acute Kidney Injury on Incidence of 30-Day Readmissions among Hospitalized Veterans Affairs Patients with Skin and Skin Structure Infections. Antimicrob Agents Chemother. 2020 Sep 21; 64(10). Patel N, Stornelli N, Sangiovanni RJ, Huang DB, Lodise TP. PMID: 32718970; PMCID: PMC7508587.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    13. Impact of a Plan of Care Protocol on Patient Outcomes in People Who Inject Drugs With Infective Endocarditis. J Infect Dis. 2020 Sep 02; 222(Suppl 5):S506-S512. Cooksey GE, Epps JL, Moye RA, Patel N, Shorman MA, Veve MP. PMID: 32877564.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    14. Comparing drug interaction frequencies of various hepatitis C treatment regimens among monoinfected patients. Ann Hepatol. 2019; 18(4):601-606. Ahmed A, Schriever C, Britt N, Yager J, Amin R, McGuey L, Patel N. PMID: 31078440.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. Short Communication: Relationship Between Contraindicated Drug-Drug Interactions and Subsequent Hospitalizations Among Patients Living with HIV Initiating Combination Antiretroviral Therapy. AIDS Res Hum Retroviruses. 2019 May; 35(5):430-433. Sangiovanni RJ, Jakeman B, Nasiri M, Ruth L, Mahatme S, Patel N. PMID: 30612438; PMCID: PMC6508060.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    16. Potential for Cost Saving with Iclaprim Owing to Avoidance of Vancomycin-Associated Acute Kidney Injury in Hospitalized Patients with Acute Bacterial Skin and Skin Structure Infections. Clin Drug Investig. 2018 Oct; 38(10):935-943. Patel N, Huang D, Lodise T. PMID: 30105549.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    17. Optimal treatment of MSSA bacteraemias: a meta-analysis of cefazolin versus antistaphylococcal penicillins. J Antimicrob Chemother. 2018 Oct 01; 73(10):2643-2651. Bidell MR, Patel N, O'Donnell JN. PMID: 30085140.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    18. Analysis of drug-drug interactions among patients receiving antiretroviral regimens using data from a large open-source prescription database. Am J Health Syst Pharm. 2018 Aug 01; 75(15):1132-1139. Patel N, Borg P, Haubrich R, McNicholl I. PMID: 29903710.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    19. Untreated depression among persons living with human immunodeficiency virus in Kazakhstan: A cross-sectional study. PLoS One. 2018; 13(3):e0193976. Terloyeva D, Nugmanova Z, Akhmetova G, Akanov A, Patel N, Lazariu V, Norelli L, McNutt LA. PMID: 29590151; PMCID: PMC5873996.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    20. Therapeutic drug monitoring in treatment-experienced HIV-infected patients receiving darunavir-based salvage regimens: A case series. Antiviral Res. 2018 Apr; 152:111-116. Landry S, Chen CN, Patel N, Tseng A, Lalonde RG, Thibeault D, Sanche S, Sheehan NL. PMID: 29458132.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCellsCTClinical Trials
    21. Reply to Chanderraj et al. Clin Infect Dis. 2017 Oct 15; 65(8):1427-1428. Britt NS, Potter EM, Patel N, Steed ME. PMID: 29017243.
      View in: PubMed   Mentions:    Fields:    
    22. Relationship Between Single Tablet Antiretroviral Regimen and Adherence to Antiretroviral and Non-Antiretroviral Medications Among Veterans' Affairs Patients with Human Immunodeficiency Virus. AIDS Patient Care STDS. 2017 Sep; 31(9):370-376. Yager J, Faragon J, McGuey L, Hoye-Simek A, Hecox Z, Sullivan S, Neubert S, Patel N. PMID: 28771023.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    23. Secular Trends in Nosocomial Vancomycin-Resistant Enterococcal Bloodstream Infections Among United States Veterans Affairs Hospitals, Fiscal Years 2004 through 2014. Infect Control Hosp Epidemiol. 2017 09; 38(9):1114-1116. Britt NS, Potter EM, McKinnell JA, Patel N, Battersby SE, Steed ME. PMID: 28693646.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    24. Effect of Continuous and Sequential Therapy among Veterans Receiving Daptomycin or Linezolid for Vancomycin-Resistant Enterococcus faecium Bacteremia. Antimicrob Agents Chemother. 2017 May; 61(5). Britt NS, Potter EM, Patel N, Steed ME. PMID: 28264856; PMCID: PMC5404546.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    25. Comparative Effectiveness and Safety of Standard-, Medium-, and High-Dose Daptomycin Strategies for the Treatment of Vancomycin-Resistant Enterococcal Bacteremia Among Veterans Affairs Patients. Clin Infect Dis. 2017 Mar 01; 64(5):605-613. Britt NS, Potter EM, Patel N, Steed ME. PMID: 28011602.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    26. Relationship between vancomycin tolerance and clinical outcomes in Staphylococcus aureus bacteraemia. J Antimicrob Chemother. 2017 Feb; 72(2):535-542. Britt NS, Patel N, Shireman TI, El Atrouni WI, Horvat RT, Steed ME. PMID: 27999028; PMCID: PMC6075607.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    27. Comparing the Frequencies of Contraindicated Drug-Drug Interactions Between Differing Antiretroviral Regimens in HIV-Infected Patients. Ann Pharmacother. 2017 May; 51(5):365-372. Jakeman B, Nasiri M, Ruth L, Morse C, Mahatme S, Patel N. PMID: 28367698.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    28. Desirable Characteristics of Hepatitis C Treatment Regimens: A Review of What We Have and What We Need. Infect Dis Ther. 2016 Sep; 5(3):299-312. Bidell MR, McLaughlin M, Faragon J, Morse C, Patel N. PMID: 27384319; PMCID: PMC5019974.
      View in: PubMed   Mentions: 12  
    29. Vancomycin 24-Hour Area under the Curve/Minimum Bactericidal Concentration Ratio as a Novel Predictor of Mortality in Methicillin-Resistant Staphylococcus aureus Bacteremia. Antimicrob Agents Chemother. 2016 May; 60(5):3070-5. Britt NS, Patel N, Horvat RT, Steed ME. PMID: 26953202; PMCID: PMC4862500.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    30. Relationship between vitamin D and human immunodeficiency virus (HIV) viral load among HIV-infected patients in Kazakhstan. J Infect Dev Ctries. 2015 Nov 30; 9(11):1277-83. Nugmanova Z, Patel N, Akhmetova GM, Kurmangalieva GS, Abdumananova MK, Akanov AA, Kovtunenko NG, McNutt LA. PMID: 26623638.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    31. Incidence and Clinical Predictors of Nonresponse to Hepatitis B Vaccination among Patients Receiving Hemodialysis: Importance of Obesity. South Med J. 2015 Sep; 108(9):567-73. Patel N, Assimon MM, Bruni E, McNutt LA, Mason DL. PMID: 26332483.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    32. Comparison of the Effectiveness and Safety of Linezolid and Daptomycin in Vancomycin-Resistant Enterococcal Bloodstream Infection: A National Cohort Study of Veterans Affairs Patients. Clin Infect Dis. 2015 Sep 15; 61(6):871-8. Britt NS, Potter EM, Patel N, Steed ME. PMID: 26063715; PMCID: PMC4551009.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansCells
    33. A Cross-Sectional Study Comparing the Frequency of Drug Interactions After Adding Simeprevir- or Sofosbuvir-Containing Therapy to Medication Profiles of Hepatitis C Monoinfected Patients. Infect Dis Ther. 2015 Jan 28; 4(1):67-78. Patel N, Nasiri M, Koroglu A, Bliss S, Davis M, McNutt LA, Miller C. PMID: 25708155; PMCID: PMC4363220.
      View in: PubMed   Mentions: 11  
    34. Prevalence of drug-drug interactions upon addition of simeprevir- or sofosbuvir-containing treatment to medication profiles of patients with HIV and hepatitis C coinfection. AIDS Res Hum Retroviruses. 2015 Feb; 31(2):189-97. Patel N, Nasiri M, Koroglu A, Amin R, McGuey L, McNutt LA, Roman M, Miller C. PMID: 25432275.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    35. Effect of Concomitant 3-Hydroxy-3-Methyl-Glutaryl-CoA Reductase Inhibitor Therapy on Creatine Phosphokinase Levels and Mortality Among Patients Receiving Daptomycin: Retrospective Cohort Study. Infect Dis Ther. 2014 Dec; 3(2):225-33. McConnell HL, Perris ET, Lowry C, Lodise T, Patel N. PMID: 25245515; PMCID: PMC4269631.
      View in: PubMed   Mentions: 5  
    36. Predicting the probability of experiencing clinically significant drug-drug interactions involving boceprevir-containing hepatitis C therapy among patients coinfected with hepatitis C and HIV. AIDS Patient Care STDS. 2014 Oct; 28(10):513-6. Patel N, Veve M, Nasiri M, Bliss S, McNutt LA, Lazariu V, Miller C. PMID: 25093994; PMCID: PMC4183897.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    37. Prevalence and Predictors of Important Telaprevir Drug Interactions Among Patients Coinfected With Hepatitis C and Human Immunodeficiency Virus. J Pharm Technol. 2014 Oct; 30(5):159-167. Patel N, Veve M, Bliss S, Nasiri M, McNutt LA, Lazariu V, Roman M, Miller C. PMID: 34860905; PMCID: PMC5990149.
      View in: PubMed   Mentions:
    38. Clinical Outcomes in Patients with Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Bloodstream Infection. Antimicrob Agents Chemother. 2013 Sep; 57(9):4252-4259. Casapao AM, Leonard SN, Davis SL, Lodise TP, Patel N, Goff DA, LaPlante KL, Potoski BA, Rybak MJ. PMID: 23796929; PMCID: PMC3754327.
      View in: PubMed   Mentions: 42     Fields:    
    39. Daptomycin pharmacokinetics and pharmacodynamics in a pooled sample of patients receiving thrice-weekly hemodialysis. Antimicrob Agents Chemother. 2013 Feb; 57(2):864-72. Butterfield JM, Mueller BA, Patel N, Cardone KE, Grabe DW, Salama NN, Lodise TP. PMID: 23208714; PMCID: PMC3553729.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    40. New option for management of HIV-1 infection in treatment-naive patients: once-daily, fixed-dose combination of rilpivirine-emtricitabine-tenofovir. HIV AIDS (Auckl). 2012; 4:61-71. Patel N, Miller CD. PMID: 22570576; PMCID: PMC3346062.
      View in: PubMed   Mentions: 3  
    41. Defining the pharmacist role in the pandemic outbreak of novel H1N1 influenza. J Am Pharm Assoc (2003). 2012; 52(6):763-7. Miller S, Patel N, Vadala T, Abrons J, Cerulli J. PMID: 23229962.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCellsPHPublic Health
    42. A comparative evaluation of adverse platelet outcomes among Veterans' Affairs patients receiving linezolid or vancomycin. J Antimicrob Chemother. 2012 Mar; 67(3):727-35. Patel N, VanDeWall H, Tristani L, Rivera A, Woo B, Dihmess A, Li HK, Smith R, Lodise TP. PMID: 22174041.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    43. Refining vancomycin protein binding estimates: identification of clinical factors that influence protein binding. Antimicrob Agents Chemother. 2011 Sep; 55(9):4277-82. Butterfield JM, Patel N, Pai MP, Rosano TG, Drusano GL, Lodise TP. PMID: 21670191; PMCID: PMC3165330.
      View in: PubMed   Mentions: 30     Fields:    Translation:HumansCells
    44. Clinical epidemiology of carbapenem-intermediate or -resistant Enterobacteriaceae. J Antimicrob Chemother. 2011 Jul; 66(7):1600-8. Patel N, Harrington S, Dihmess A, Woo B, Masoud R, Martis P, Fiorenza M, Graffunder E, Evans A, McNutt LA, Lodise TP. PMID: 21508008.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    45. Vancomycin: we can't get there from here. Clin Infect Dis. 2011 Apr 15; 52(8):969-74. Patel N, Pai MP, Rodvold KA, Lomaestro B, Drusano GL, Lodise TP. PMID: 21460308.
      View in: PubMed   Mentions: 65     Fields:    Translation:HumansCells
    46. Pharmacokinetics and pharmacodynamics of intravenous daptomycin during continuous ambulatory peritoneal dialysis. Clin J Am Soc Nephrol. 2011 May; 6(5):1081-8. Cardone KE, Lodise TP, Patel N, Hoy CD, Meola S, Manley HJ, Drusano GL, Grabe DW. PMID: 21393490; PMCID: PMC3087774.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCellsCTClinical Trials
    47. Predictors of clinically significant drug-drug interactions among patients treated with nonnucleoside reverse transcriptase inhibitor-, protease inhibitor-, and raltegravir-based antiretroviral regimens. Ann Pharmacother. 2011 Mar; 45(3):317-24. Patel N, Abdelsayed S, Veve M, Miller CD. PMID: 21386025.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    48. Use of pharmacokinetic and pharmacodynamic principles to determine optimal administration of daptomycin in patients receiving standardized thrice-weekly hemodialysis. Antimicrob Agents Chemother. 2011 Apr; 55(4):1677-83. Patel N, Cardone K, Grabe DW, Meola S, Hoy C, Manley H, Drusano GL, Lodise TP. PMID: 21282429; PMCID: PMC3067175.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    49. Determination of antibiotic dosage adjustments in patients with renal impairment: elements for success. J Antimicrob Chemother. 2010 Nov; 65(11):2285-90. Patel N, Scheetz MH, Drusano GL, Lodise TP. PMID: 20736235.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    50. Nonnucleoside reverse transcriptase inhibitor resistance and the role of the second-generation agents. Ann Pharmacother. 2010 Jan; 44(1):157-65. Adams J, Patel N, Mankaryous N, Tadros M, Miller CD. PMID: 19996323.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    51. Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients. Clin Infect Dis. 2009 Aug 15; 49(4):507-14. Lodise TP, Patel N, Lomaestro BM, Rodvold KA, Drusano GL. PMID: 19586413.
      View in: PubMed   Mentions: 168     Fields:    Translation:Humans
    52. Outcomes of extended infusion piperacillin/tazobactam for documented Gram-negative infections. Diagn Microbiol Infect Dis. 2009 Jun; 64(2):236-40. Patel GW, Patel N, Lat A, Trombley K, Enbawe S, Manor K, Smith R, Lodise TP. PMID: 19500529.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    53. The effect of time to antifungal therapy on mortality in Candidemia associated septic shock. Am J Ther. 2009; 16(6):508-11. Patel GP, Simon D, Scheetz M, Crank CW, Lodise T, Patel N. PMID: 19531934.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    54. Relationship between various definitions of prior antibiotic exposure and piperacillin-tazobactam resistance among patients with respiratory tract infections caused by Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2008 Aug; 52(8):2933-6. Patel N, McNutt LA, Lodise TP. PMID: 18519718; PMCID: PMC2493121.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    55. Pharmacokinetic and pharmacodynamic profile of ceftobiprole. Diagn Microbiol Infect Dis. 2008 May; 61(1):96-102. Lodise TP, Patel N, Renaud-Mutart A, Gorodecky E, Fritsche TR, Jones RN. PMID: 18384996.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    56. Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections: impact of delayed appropriate antibiotic selection. Antimicrob Agents Chemother. 2007 Oct; 51(10):3510-5. Lodise TP, Patel N, Kwa A, Graves J, Furuno JP, Graffunder E, Lomaestro B, McGregor JC. PMID: 17646415; PMCID: PMC2043259.
      View in: PubMed   Mentions: 87     Fields:    Translation:Humans
    57. Identification of patients with Pseudomonas aeruginosa respiratory tract infections at greatest risk of infection with carbapenem-resistant isolates. Infect Control Hosp Epidemiol. 2007 Aug; 28(8):959-65. Lodise TP, Miller C, Patel N, Graves J, McNutt LA. PMID: 17620244.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    58. Reimbursement for clinical services. Am J Health Syst Pharm. 2007 May 01; 64(9):926. Patel N, Murdico AT. PMID: 17468146.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    Nimish's Networks
    Concepts (241)
    Derived automatically from this person's publications.
    _
    Co-Authors (7)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _